SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-038408
Filing Date
2023-10-26
Accepted
2023-10-26 16:56:53
Documents
17
Period of Report
2023-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 72089
2 ex2-1.htm EX-2.1 526114
3 ex2-2.htm EX-2.2 64952
4 ex99-1.htm EX-99.1 36244
5 ex99-1_001.jpg GRAPHIC 4328
6 ex99-1_002.jpg GRAPHIC 6069
  Complete submission text file 0001493152-23-038408.txt   1011264

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE invo-20231022.xsd EX-101.SCH 3033
8 XBRL LABEL FILE invo-20231022_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE invo-20231022_pre.xml EX-101.PRE 22371
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3207
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 231350864
SIC: 3841 Surgical & Medical Instruments & Apparatus